174 related articles for article (PubMed ID: 32934781)
1. Down syndrome iPSC model: endothelial perspective on tumor development.
Perepitchka M; Galat Y; Beletsky IP; Iannaccone PM; Galat V
Oncotarget; 2020 Sep; 11(36):3387-3404. PubMed ID: 32934781
[TBL] [Abstract][Full Text] [Related]
2. iPSC-derived progenitor stromal cells provide new insights into aberrant musculoskeletal development and resistance to cancer in down syndrome.
Galat Y; Perepitchka M; Elcheva I; Iannaccone S; Iannaccone PM; Galat V
Sci Rep; 2020 Aug; 10(1):13252. PubMed ID: 32764607
[TBL] [Abstract][Full Text] [Related]
3. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome.
M Lee Y; Zampieri BL; Scott-McKean JJ; Johnson MW; Costa ACS
Stem Cells Transl Med; 2017 Jun; 6(6):1465-1476. PubMed ID: 28371411
[TBL] [Abstract][Full Text] [Related]
4. Modeling neurogenesis impairment in Down syndrome with induced pluripotent stem cells from Trisomy 21 amniotic fluid cells.
Lu HE; Yang YC; Chen SM; Su HL; Huang PC; Tsai MS; Wang TH; Tseng CP; Hwang SM
Exp Cell Res; 2013 Feb; 319(4):498-505. PubMed ID: 23041301
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation profiling in Trisomy 21 females with and without breast cancer.
Bejaoui Y; Alresheq S; Durand S; Vilaire-Meunier M; Maillebouis L; Zen AAH; Mégarbané A; Hajj NE
Front Oncol; 2023; 13():1203483. PubMed ID: 37538118
[TBL] [Abstract][Full Text] [Related]
6. Down-syndrome-induced senescence disrupts the nuclear architecture of neural progenitors.
Meharena HS; Marco A; Dileep V; Lockshin ER; Akatsu GY; Mullahoo J; Watson LA; Ko T; Guerin LN; Abdurrob F; Rengarajan S; Papanastasiou M; Jaffe JD; Tsai LH
Cell Stem Cell; 2022 Jan; 29(1):116-130.e7. PubMed ID: 34995493
[TBL] [Abstract][Full Text] [Related]
7. [Trisomy 21 and breast cancer: A genetic abnormality which protects against breast cancer?].
Martel-Billard C; Cordier C; Tomasetto C; Jégu J; Mathelin C
Gynecol Obstet Fertil; 2016 Apr; 44(4):211-7. PubMed ID: 27032759
[TBL] [Abstract][Full Text] [Related]
8. Trisomy 21 Alters Cell Proliferation and Migration of iPSC-Derived Cardiomyocytes on Type VI Collagen.
Reeser RS; Salazar AK; Prutton KM; Roede JR; VeDepo MC; Jacot JG
Cell Mol Bioeng; 2024 Feb; 17(1):25-34. PubMed ID: 38435791
[TBL] [Abstract][Full Text] [Related]
9. Chromosome silencing in vitro reveals trisomy 21 causes cell-autonomous deficits in angiogenesis and early dysregulation in Notch signaling.
Moon JE; Lawrence JB
Cell Rep; 2022 Aug; 40(6):111174. PubMed ID: 35947952
[TBL] [Abstract][Full Text] [Related]
10. Transcriptome and Proteome Profiling of Neural Induced Pluripotent Stem Cells from Individuals with Down Syndrome Disclose Dynamic Dysregulations of Key Pathways and Cellular Functions.
Sobol M; Klar J; Laan L; Shahsavani M; Schuster J; Annerén G; Konzer A; Mi J; Bergquist J; Nordlund J; Hoeber J; Huss M; Falk A; Dahl N
Mol Neurobiol; 2019 Oct; 56(10):7113-7127. PubMed ID: 30989628
[TBL] [Abstract][Full Text] [Related]
11. Trisomy 21 causes changes in the circulating proteome indicative of chronic autoinflammation.
Sullivan KD; Evans D; Pandey A; Hraha TH; Smith KP; Markham N; Rachubinski AL; Wolter-Warmerdam K; Hickey F; Espinosa JM; Blumenthal T
Sci Rep; 2017 Nov; 7(1):14818. PubMed ID: 29093484
[TBL] [Abstract][Full Text] [Related]
12. Genome-wide microRNA expression profiling in placentas of fetuses with Down syndrome.
Lim JH; Kim DJ; Lee DE; Han JY; Chung JH; Ahn HK; Lee SW; Lim DH; Lee YS; Park SY; Ryu HM
Placenta; 2015 Mar; 36(3):322-8. PubMed ID: 25595853
[TBL] [Abstract][Full Text] [Related]
13. Integrated differential transcriptome maps of Acute Megakaryoblastic Leukemia (AMKL) in children with or without Down Syndrome (DS).
Pelleri MC; Piovesan A; Caracausi M; Berardi AC; Vitale L; Strippoli P
BMC Med Genomics; 2014 Dec; 7():63. PubMed ID: 25476127
[TBL] [Abstract][Full Text] [Related]
14. Early lineage priming by trisomy of Erg leads to myeloproliferation in a Down syndrome model.
Ng AP; Hu Y; Metcalf D; Hyland CD; Ierino H; Phipson B; Wu D; Baldwin TM; Kauppi M; Kiu H; Di Rago L; Hilton DJ; Smyth GK; Alexander WS
PLoS Genet; 2015 May; 11(5):e1005211. PubMed ID: 25973911
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide gene expression analysis in the placenta from fetus with trisomy 21.
Lim JH; Han YJ; Kim HJ; Kwak DW; Park SY; Chun SH; Ryu HM
BMC Genomics; 2017 Sep; 18(1):720. PubMed ID: 28899343
[TBL] [Abstract][Full Text] [Related]
16. Solid malignancies in individuals with Down syndrome: a case presentation and literature review.
Bratman SV; Horst KC; Carlson RW; Kapp DS
J Natl Compr Canc Netw; 2014 Nov; 12(11):1537-45. PubMed ID: 25361800
[TBL] [Abstract][Full Text] [Related]
17. Increased Skin Tumor Incidence and Keratinocyte Hyper-Proliferation in a Mouse Model of Down Syndrome.
Yang A; Currier D; Poitras JL; Reeves RH
PLoS One; 2016; 11(1):e0146570. PubMed ID: 26752700
[TBL] [Abstract][Full Text] [Related]
18. Expression of interferon-γ, interferon-α and related genes in individuals with Down syndrome and periodontitis.
Tanaka MH; Giro EM; Cavalcante LB; Pires JR; Apponi LH; Valentini SR; Spolidório DM; Capela MV; Rossa C; Scarel-Caminaga RM
Cytokine; 2012 Dec; 60(3):875-81. PubMed ID: 22995210
[TBL] [Abstract][Full Text] [Related]
19. The Pattern of Malignancies in Down Syndrome and Its Potential Context With the Immune System.
Satgé D; Seidel MG
Front Immunol; 2018; 9():3058. PubMed ID: 30631328
[TBL] [Abstract][Full Text] [Related]
20. A Trisomy 21 Lung Cell Atlas.
Bhattacharya S; Cherry C; Deutsch G; ; Glass IA; Mariani TJ; Alam DA; Danopoulos S
bioRxiv; 2023 Apr; ():. PubMed ID: 37066313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
